# Osteitis Fibrosa Cystica: An Unusual Cause of Left‐Sided Chest Pain

**Authors:** Raahima Habib, Maha Anjum, Ayesha Mahmood, Nabiha Rizvi

PMC · DOI: 10.1155/crin/3576066 · Case Reports in Nephrology · 2026-01-08

## TL;DR

A young man with kidney disease experienced chest pain due to a rare bone condition linked to high parathyroid hormone levels, which was managed with supplements.

## Contribution

This case highlights osteitis fibrosa cystica as a rare but important cause of chest pain in patients with end-stage renal disease.

## Key findings

- The patient had elevated PTH levels and abnormal calcium/phosphorus levels consistent with secondary hyperparathyroidism.
- Imaging revealed lytic rib lesions consistent with osteitis fibrosa cystica.
- Conservative management with calcium and vitamin D resolved symptoms and normalized calcium and phosphorus levels.

## Abstract

We report a case of osteitis fibrosa cystica resulting from secondary hyperparathyroidism in a 21‐year‐old male patient with end‐stage renal disease. The patient presented with persistent, moderate chest pain localized to the left fifth and sixth ribs for eight months. A chest X‐ray revealed well‐defined, expansile lytic lesions in these ribs. Prior testing showed elevated parathyroid hormone (PTH) levels for five years, along with decreased serum calcium and elevated phosphorus levels. Findings from ultrasound and SPECT scans were consistent with hyperparathyroidism. Repeat laboratory tests showed a PTH level of 939.8 pg/mL (normal: 10–69 pg/mL), calcium level of 8.3 mg/dL (normal: 8.4–10.2 mg/dL), and phosphorus level of 5.1 mg/dL (normal: 2.5–5.0 mg/dL). The patient declined surgical intervention and was managed conservatively with calcium and vitamin D supplementation. Within 4 weeks, symptoms resolved and calcium and phosphorus levels normalized, although PTH levels remained elevated. Osteitis fibrosa cystica can be challenging to diagnose due to its rarity, especially in developed countries, and its nonspecific clinical presentation. This case highlights the importance of considering this diagnosis and outlines an approach to management in resource‐limited settings.

## Linked entities

- **Chemicals:** calcium (PubChem CID 5460341), phosphorus (PubChem CID 139579)
- **Diseases:** osteitis fibrosa cystica (MONDO:0005890), secondary hyperparathyroidism (MONDO:0006964), end-stage renal disease (MONDO:0004375)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** secondary hyperparathyroidism (MESH:D006962), end-stage renal disease (MESH:D007676), Chest Pain (MESH:D002637), hyperparathyroidism (MESH:D006961), Osteitis Fibrosa Cystica (MESH:D010002)
- **Chemicals:** phosphorus (MESH:D010758), vitamin D (MESH:D014807), calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12783687/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12783687/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12783687/full.md

---
Source: https://tomesphere.com/paper/PMC12783687